ABSTRACT
INTRODUCTION
Epilepsy is a disorder of the brain that is characterized by an enduring predisposition to generate seizures and by its neurobiological, cognitive, psychological, and social consequences.
1 WHO estimates that eight people per 1000 worldwide have this disease. 2 The prevalence of epilepsy in developing countries is usually higher than in developed countries. [3] [4] [5] Epilepsy is a common and diverse disorder with many different causes. Outcomes are varied with 60-70% of newly diagnosed people rapidly entering remission after starting treatment, and 20-30% developing a drugresistant epilepsy with consequent clinical and psychosocial distress. 6 Treatment for most patients is with antiepileptic drugs, which carry risks of acute idiosyncratic reactions, dose-related and chronic toxic effects, and teratogenicity. About one third of patients with a first unprovoked seizure will have further seizures within five years, and about three quarters of those with two or three unprovoked seizures have further seizures within four years.
7
Although substantial economic development and improvement of health services have occurred, Asia is a heterogeneous and resource-constrained continent. Although much research is done in Asia, information about the recognition of the burden created by the disease is scarce. In 1997, Jallon reviewed studies from Asia, 8 mostly done in the 1980s, and showed a prevalence varying from 1.5 per 1000 in Japan to 10.0 per 1000 in Pakistan.
Among 50 million people with epilepsy worldwide, 90% of them are found in developing Countries and 90% of these patients are not receiving adequate treatment. 9 They could live normal lives if treated. This huge treatment gap may be due to the limited knowledge, poverty, cultural beliefs, stigma, poor health delivery infrastructure like inadequate supplies of antiepileptic drugs, and shortage of trained health care workers. The prevalence and incidence of epilepsy in Asia is similar to the West but reversible etiologies such as head trauma, infections, stroke, obstetric care are probably more important in Asia. 10 Nepal is one of the poorest countries in the world and it is not uncommon to see huge untreated epilepsy patients in our country. The prevalence rate of epilepsy in Nepal is 7.3 per 1000 population with the treatment gap of over 80%.
11 People with low socioeconomic status mostly living in the rural areas are found to be more affected. 12 Studies have shown that neurocysticercosis and calcified lesions are the commonest radiological findings. 13, 14 People suffering from epilepsy in our country do not have good quality of life because of their poor epilepsy control.
In practice, there has been no agreement on an absolute number of seizures required for them to be considered recurrent. A few researchers have defined the term "epilepsy" to include patients with a single seizure and a few have required three unprovoked seizures. 15, [17] [18] [19] Most recent clinical and epidemiologic studies have required two unprovoked seizures as a minimal criterion for the diagnosis. 12 The present study was undertaken to identify those factors which were associated with recurrence of seizure in patients from Nepal.
METHODS
It is a Descriptive Cross-sectional study which was conducted in Tribhuvan University Teaching Hospital from January 2013 to January 2014.
Inclusion Criteria
All the patients attending to neurology outpatient department and those patients admitted to neurology ward and ICU with recurrent seizure.
Exclusion Criteria
1. Patients presenting with a history of single seizure.
Patients presenting with a history of multiple seizures
within 24 hours without past history of seizure.
3. Those who refused to participate in the study.
Statistical Analysis
Data were entered on the computer by using the SPSS Statistical Software (Version 16; SPSS; Chicago, IL) and were analyzed on the same software. Wherever applicable, the data were presented using both the tabular method and descriptive statistics. The strength of associations had been estimated by linear regression analysis and t-test which were used as appropriate. P value of less than 0.05 was considered statistically significant.
RESULTS
The demographic profile of the patients and the clinical characteristics of their seizure are presented in the following 
DISCUSSION
The result from our study showed that the frequency of seizure after starting treatment increased if the number of seizure before starting medication was high. This finding may be because those patients with higher frequency of seizure may have developed intractable drug resistant seizure. This resulted in patients having further seizure despite beginning medication. The relatively low risk of further seizures among persons with a single unprovoked seizure contrasts sharply with the higher risk after two or more unprovoked seizures.
In practice, there has been no agreement on an absolute number of seizures required for them to be considered recurrent. A few researchers have defined the term "epilepsy" to include patients with a single seizure and a few have required three unprovoked seizures. [15] [16] [17] [18] [19] Most recent clinical and epidemiologic studies have required two unprovoked seizures as a minimal criterion for the diagnosis. History of febrile convulsion was associated with higher seizure frequency. However we did not find any association between a history of status epilepticus and seizure frequency.
We did not find any association between Abnormal EEG or having a family history of epilepsy with higher seizure frequency. In our study, the precipitants in decreasing order were sleep deprivation, Alcohol intake, emotional stress, fatigue and hunger. The above factors have been found to lower the seizure threshold. Sleep deprivation has been particularly known to precipitate seizure like juvenile myoclonic epilepsy. Similarly chronic alcoholic may develop seizure during bout of alcohol intoxication which causes lowering of seizure threshold. However they more often develop acute symptomic seizure during period of alcohol withdrawal.
Majority of our patients reported taking their medications regularly. Patients who were noncompliant to medication had significantly higher seizure frequency than those patients who were compliant to their medication. Those patients who took their medicines irregularly often had their drug level in the sub-therapeutic level thus precipitating seizure in them.
Unlike study done by Rajbhandari in Nepal, 11 our study showed slightly different percentage for causal factors of seizure probably because our study was done in patients with recurrent seizure unlike the former study which included patients with first and recurrent seizure. Both the studies however found neurocystercosis to be the most common identifiable cause of seizure. The presence of abnormal neuroimaging was not significantly associated with increased seizure frequency. The cause of seizure did not predict higher seizure frequency. Few patients developed adverse effect requiring them to change their antiepileptic medication.
CONCLUSION
Most of the patients with recurrent seizure had identifiable cause. Neurocysticercosis was the most common cause found on neuroimaging. Cerebral infarction, neuroinfection eg. Tubercular meningitis and encephalitis were also common causes of recurrent seizure. Increased number of seizure before starting medication, history of febrile convulsion, noncompliance with medication, presence of precipitants and abnormal finding on physical examination were associated with increased frequency of seizure.
